DNMT3A-R882 mutations intrinsically drive dysfunctional neutropoiesis from human haematopoietic stem cells
Giovanna ManticaiD, Aditi VediiD, Amos TuvaliD, Hector Huerga EncaboiD, Daniel Hayler, Aleksandra KrzywoniD, Emily MitchelliD, William G. DunniD, Tamir BiezuneriD, Hugo P. BastosiD, Kendig ShamiD, Antonella SantoroiD, Joe LeeiD, Nick WilliamsiD, Adi Danin, Noa Chapal-Ilani, Yoni MoskovitziD, Andrea ArrudaiD, Edoardo FiorilloiD, Valeria OrrùiD, Michele MarongiuiD, Eoin F. McKinneyiD, Francesco CuccaiD, Matthew ColliniD, Mark David MindeniD, , Elisa LaurentiiD
Abstract
Clonal haematopoiesis (CH) arises from the expansion of hematopoietic stem cells (HSCs) carrying leukaemia-associated somatic mutations. CH is linked to pathological immune dysregulation and a greater risk of age-related inflammatory diseases. Yet, how CH mutations impact HSC differentiation into immune effector cells remains understudied. Here, we report a single-cell resolution functional and multi-omic investigation of HSC clonal and differentiation dynamics in individuals with DNMT3A-R882 CH. DNMT3A-R882 reshapes the clonal architecture of haematopoiesis towards an aged phylogenetic structure. Functionally, DNMT3A-R882 HSCs produce decreased monocytic output but more abundant and mature neutrophil progeny compared to WT HSCs in the same individual. Whereas DNMT3A-R882 myeloid progenitors display attenuated inflammatory transcriptional programmes, DNMT3A- R882 mature neutrophils acquire proinflammatory and immunomodulatory features typical of maladaptive immunity and CH co-morbidities. Our findings, validated in humanised mice, identify aberrant DNMT3A-R882 HSC-driven neutropoiesis as a key link between CH, immune dysregulation and risk of inflammatory disease.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 2
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Neutrophil-Derived S100A8/A9 Drives Inflammation that Promotes Dnmt3a -Mutant Hematopoiesis
Jayna J. Mistry, Natalie R Fournier, … Jennifer J. Trowbridge·bioRxiv·Jun 27, 2026
- Delayed Trp53 activation protects Dnmt3a-mutant hematopoietic stem cells from inflammatory attrition.
Ludovica Marando, George Giotopoulos, … Brian J.P. Huntly·bioRxiv·Jan 27, 2025
- Single-cell multi-omics of human clonal hematopoiesis reveals that DNMT3A R882 mutations perturb early progenitor states through selective hypomethylation
- Retrotransposons Promote Dnmt3a-Mutant Clonal Hematopoiesis Through Aging-Related Stromal Inflammation
Qiongdi Zhang, Wenhuo Hu, … Sisi Zheng·bioRxiv·Jul 2, 2026
- Selective advantage of mutant stem cells in clonal hematopoiesis occurs by attenuating the deleterious effects of inflammation and aging
N. A. Jakobsen, S. Turkalj, … P. Vyas·bioRxiv·Sep 12, 2023
- Mesenchymal Stromal Cell Senescence Induced by Dnmt3a-Mutant Hematopoietic Cells is a Targetable Mechanism Driving Clonal Hematopoiesis and Initiation of Hematologic Malignancy
Jayna J. Mistry, Kira A. Young, … Jennifer J. Trowbridge·bioRxiv·Mar 28, 2024